Aurobindo Pharma
Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives.
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
Dr. Reddy’s Laboratories – Good Health Can’t Wait. Values. In pursuit of providing affordable and innovative medicines for healthier lives, we will create an environment of innovation and learning while continuously reaching for higher levels of excellence. INTEGRITY AND TRANSPARENCY. SAFETY. QUALITY. PRODUCTIVITY. RESPECT FOR THE INDIVIDUAL.
4 days ago · Dr Reddys Labs Share Price: Find the latest news on Dr Reddys Labs Stock Price. Get all the information on Dr Reddys Labs with historic price charts for NSE / BSE.
15 hours ago · Dr. Reddy's Laboratories closed at Rs 6749.90, reflecting a robust trading session with a volume of 558,911 shares, surpassing the 7-day average volume of 453,711. This uptick indicates strong investor interest in the stock. 08:32:15 AM IST, 30 Sep 2024.
For any Dr. Reddy’s product availability related issues, please contact us: Phone: 1800 425 0014 (Monday to Friday, 8AM to 6PM IST) Email:customerservices%40drreddys.com
Dr.reddy's Laboratories Ltd is a Public incorporated on 24 February 1984. It is classified as Non-government company and is registered at Registrar of Companies, ROC Hyderabad. Its authorized share capital is Rs. 1,450,000,000 and its paid up capital is Rs. 834,091,330.
3 days ago · Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned subsidiary, Dr Reddy’s Laboratories SA, Switzerland (DRL SA).
Sep 21, 2024 · Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.
18 hours ago · Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category.
